India releases hydroxychloroquine stocks amid pressure from Donald Trump| ABP UNCUT

India has approved some exports of hydroxychloroquine, an anti-malaria drug being touted as a possible coronavirus treatment, after apparent pressure from Donald Trump, who has been urging Americans to take it.
India, the world’s largest producer of hydroxychloroquine, had put a temporary export ban on the drug in order to preserve domestic stocks.